Compare Adaptive Biotechnologies Corp (ADPT) vs Southwest Airlines Co (LUV) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Southwest Airlines Co — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while Southwest Airlines Co trades at $48.37 (market cap $24.16B). The key difference: Southwest Airlines Co is far larger — about 7.3× Adaptive Biotechnologies Corp's market cap, and Southwest Airlines Co pays a 1.46% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | LUV | |
|---|---|---|
Market Cap | $3.33B | $24.16B |
Sector | Health | Industrials |
52-Week High | $22.37 | $54.80 |
52-Week Low | $10.24 | $29.06 |
Enterprise Value | $3.19B | $27.23B |
Dividend Yield | — | 1.46% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Southwest Airlines Co
Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded. Southwest operates over 700 aircraft in an all-Boeing 737 fleet. Despite expanding into longer routes and business travel, the airline still specializes in short-haul leisure flights, using a point-to-point network. Southwest operates a low-cost carrier business model.
Read more on LUV →
